Membrane receptor signaling and control of DNA repair after exposure to ionizing radiation

Area of Science:

• Oncology
• Molecular Biology
• Radiotherapy

Background:

• Over-expression or mutation of erbB receptors, including EGFR, contributes to chemo- and radiotherapy resistance.
• Aberrant EGFR signaling activates cell survival pathways, leading to resistance against radiation therapy.

Purpose of the Study:

• To review the role of EGFR and erbB2 in signaling pathways activated by ionizing radiation (IR).
• To explain the radiosensitizing effects of EGFR antagonists by highlighting their impact on DNA double-strand break (DNA-DSB) repair.

Main Methods:

• Literature review focusing on EGFR and erbB2 signaling pathways.
• Analysis of the non-homologous end-joining (NHEJ) DNA repair pathway.
• Examination of PI3K/Akt signaling activation by IR.

Main Results:

• EGFR signaling activation promotes tumor cell survival and resistance to radiotherapy.
• EGFR antagonists suppress DNA-DSB repair via the NHEJ pathway, enhancing radiosensitivity.
• Targeting EGFR signaling can overcome resistance mechanisms in cancer treatment.

Conclusions:

• Understanding erbB-signaling mechanisms in DNA-DSB repair is crucial for developing novel molecular targeting strategies.
• Targeting EGFR and related pathways offers a promising approach to enhance radiotherapy efficacy.
• Further research can translate these findings into clinical applications for improved cancer treatment.